Given the critical need for early prediction of RP-ILD to inform therapeutic decisions in clinical practice, our study used indirect immunofluorescence (IIF) to analyze anti-MDA5 IgG subtype distribution and titers in MDA5+ DM-ILD patients and evaluated their diagnostic significance for RP-ILD. The gene discussed is IFIH1; the disease is dermatomyositis.